[go: up one dir, main page]

CO5180542A1 - Inhibidores de proteasas 1,3-dioxepin-5-ona con anillo de 7 miembros - Google Patents

Inhibidores de proteasas 1,3-dioxepin-5-ona con anillo de 7 miembros

Info

Publication number
CO5180542A1
CO5180542A1 CO00019250A CO00019250A CO5180542A1 CO 5180542 A1 CO5180542 A1 CO 5180542A1 CO 00019250 A CO00019250 A CO 00019250A CO 00019250 A CO00019250 A CO 00019250A CO 5180542 A1 CO5180542 A1 CO 5180542A1
Authority
CO
Colombia
Prior art keywords
alkyl
het
group
alkenyl
alkoxy
Prior art date
Application number
CO00019250A
Other languages
English (en)
Spanish (es)
Inventor
Scott Kevin Thompson
Daniel Frank Veber
Marie Halbert Stacie
Nidamarthy Sirishkumar
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of CO5180542A1 publication Critical patent/CO5180542A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D321/00Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02Seven-membered rings
    • C07D321/04Seven-membered rings not condensed with other rings
    • C07D321/061,3-Dioxepines; Hydrogenated 1,3-dioxepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
CO00019250A 1999-03-16 2000-03-16 Inhibidores de proteasas 1,3-dioxepin-5-ona con anillo de 7 miembros CO5180542A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12465999P 1999-03-16 1999-03-16

Publications (1)

Publication Number Publication Date
CO5180542A1 true CO5180542A1 (es) 2002-07-30

Family

ID=22416114

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00019250A CO5180542A1 (es) 1999-03-16 2000-03-16 Inhibidores de proteasas 1,3-dioxepin-5-ona con anillo de 7 miembros

Country Status (9)

Country Link
EP (1) EP1161237A4 (fr)
JP (1) JP2002539160A (fr)
AR (1) AR022927A1 (fr)
AU (1) AU3888200A (fr)
CO (1) CO5180542A1 (fr)
HK (1) HK1043534A1 (fr)
PE (1) PE20001564A1 (fr)
UY (1) UY26026A1 (fr)
WO (1) WO2000054769A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
EP1232155A4 (fr) 1999-11-10 2002-11-20 Smithkline Beecham Corp Inhibiteurs de protease
EP1232154A4 (fr) 1999-11-10 2004-06-23 Smithkline Beecham Corp Inhibiteurs de protease
AU1474801A (en) 1999-11-10 2001-06-06 Smithkline Beecham Corporation Protease inhibitors
BR0109356A (pt) 2000-03-21 2003-06-03 Smithkline Beecham Corp Inibidores de protease
US7282512B2 (en) 2002-01-17 2007-10-16 Smithkline Beecham Corporation Cycloalkyl ketoamides derivatives useful as cathepsin K inhibitors
JP2004196696A (ja) * 2002-12-18 2004-07-15 Kyowa Hakko Kogyo Co Ltd 関節炎の予防剤または治療剤
HUE043221T2 (hu) * 2011-05-27 2019-08-28 Lexicon Pharmaceuticals Inc Notum pektinacetilészteráz 4H-tieno[3,2-C]kromén-alapú inhibitorai és alkalmazási eljárásaik

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374623A (en) * 1992-08-20 1994-12-20 Prototek, Inc. Cysteine protease inhibitors effective for in vivo use
ATE171171T1 (de) * 1992-12-25 1998-10-15 Mitsubishi Chem Corp Alpha-aminoketon derivate

Also Published As

Publication number Publication date
WO2000054769A1 (fr) 2000-09-21
HK1043534A1 (zh) 2002-09-20
JP2002539160A (ja) 2002-11-19
UY26026A1 (es) 2000-10-31
EP1161237A4 (fr) 2002-03-27
EP1161237A1 (fr) 2001-12-12
PE20001564A1 (es) 2001-02-08
AR022927A1 (es) 2002-09-04
AU3888200A (en) 2000-10-04

Similar Documents

Publication Publication Date Title
NO20021399L (no) Kazolinderivater og deres anvendelse som farmasöyter
CO5261616A1 (es) Inhibidores no peptidicos de la union celular dependientes de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
AR058614A1 (es) Compuesto de azaindol , composicion que lo comprende y su uso para preparar un medicamento
TR200400185T4 (tr) PDE 5 inhibitörleri olarak, 8-kuinolinkisantin ve 8-izokuinolinkisantin türevleri.
CO5261607A1 (es) Nuevo uso
DE50309753D1 (de) Neue Kupplerkomponenten
SE9703375D0 (sv) A new combination
CO5180542A1 (es) Inhibidores de proteasas 1,3-dioxepin-5-ona con anillo de 7 miembros
SE9603283D0 (sv) New compounds
SE9703376D0 (sv) A new combination
AR029343A1 (es) USO DE UN ANTAGONISTA DE NMDA DE BAJA AFINIDAD PARA EL TRATAMIENTO DE LA DEPRESIoN
AR054212A1 (es) Derivados de bisarilurea sustituidos con heterociclos, composicion farmaceutica y un metodo para prepararla y compuestos intermediarios de sintesis
CO5261594A1 (es) Inhibidores de myt1 cinasa
DE60121587D1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
DK0799210T3 (da) Piperazin-2,5-dionderivater som modulatorer af multiresistens
DE69103968D1 (de) 2-(Aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre Herstellung und ihre Anwendung in der Therapeutik.
CO5271679A1 (es) Inhibidores de proteasa 7-14 miembros
AR044175A1 (es) Compuestos de cefemo
CO5170535A1 (es) Derivados de n-[2-(4-aminofenil)etil]2,3-dihidro-1,4- benzodioxin-2-metanamina, su preparacion y su aplciacion en terapeutica
AR039402A1 (es) Derivados de acil-3-carboxifenilurea, procedimientos y su uso como antidiabetico
CO5180541A1 (es) Inhibidores de proteasa del tipo de 1,3-diaminocetonas con anillo de 8-14 miembros
CO5280088A1 (es) Inhibidores de proteasa
NO910167D0 (no) Haarfargemiddel.
AR020773A1 (es) Compuesto derivados de 3-(tetrahidropiridin-4-il)indol, metodo para prepararlo, una composicion farmaceutica que los contiene, metodo para preparar dicha composicion y uso del compuesto
CO5180536A1 (es) Inhibidores de proteasas catepsina

Legal Events

Date Code Title Description
FA Application withdrawn